Stacie B. Dusetzina

1. Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States
   2016/03/04 by William V. Padula, Richard A. Larson, Stacie B. Dusetzina +22 · 26 citations
   Medicine · Social Sciences · Economics, Econometrics and Finance · #Chronic Myeloid Leukemia Treatments #Health, Education, and Cultural Studies #Economic and Financial Impacts of Cancer